Membrane Lipid Remodeling Takes Center Stage in Growth Factor Receptor-Driven Cancer Development.
Journal
Cell metabolism
ISSN: 1932-7420
Titre abrégé: Cell Metab
Pays: United States
ID NLM: 101233170
Informations de publication
Date de publication:
03 09 2019
03 09 2019
Historique:
entrez:
5
9
2019
pubmed:
5
9
2019
medline:
28
4
2020
Statut:
ppublish
Résumé
Enhanced growth factor signaling is a hallmark of cancer, allowing cancer cells to thrive in a challenging environment. In this issue of Cell Metabolism, Bi et al. (2019) identify LPCAT1, a key membrane lipid remodeling enzyme, as a central link between genetically driven growth factor receptor expression, signaling, and tumor growth, highlighting lipid remodeling as a therapeutic target in cancer.
Identifiants
pubmed: 31484051
pii: S1550-4131(19)30445-0
doi: 10.1016/j.cmet.2019.08.016
pii:
doi:
Substances chimiques
Intercellular Signaling Peptides and Proteins
0
Membrane Lipids
0
Receptors, Growth Factor
0
Types de publication
Journal Article
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
407-408Commentaires et corrections
Type : CommentOn
Informations de copyright
Copyright © 2019. Published by Elsevier Inc.